Description
Cyclophosphosphamide is a medication used in cancer treatment. It belongs to a class of drugs called alkylating agents. In clinical trials for colorectal cancer (CRC), it has been studied, often in combination with other therapies, particularly in patients whose tumors have specific characteristics, such as HER2 expression or mutation. The trials involving cyclophosphosphamide in CRC are generally in early phases (Phase 1), meaning they are primarily focused on determining safety and finding the right dose, rather than confirming effectiveness. It's often used as part of a conditioning regimen before stem cell transplantation or in combination with other treatments to prepare the body for therapy.
Mechanism of Action
Cyclophosphosphamide works by damaging the DNA inside cancer cells. This damage prevents the cancer cells from dividing and growing, ultimately leading to their death. It is an alkylating agent, meaning it adds an alkyl group to DNA, interfering with its normal function. It is often used in combination with other chemotherapy drugs or therapies to enhance their effectiveness or as part of a conditioning regimen.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.